The above network-based data imply that BHGZD might reverse the imbalance of the “immune-inflammation” system during active RA progression via regulating TLR4/PI3K/AKT/NFκB/NLRP3 signaling. This evidence concerns the gene AKT1 and rheumatoid arthritis.